Skip to main content

Table 5 Relation between mRECIST and vRECIST methods in assessment of the therapeutic response whether responders or non-responders.

From: Role of multislice computed tomography 3D volumetric analysis in the assessment of the therapeutic response of hepatocellular carcinoma after transarterial chemoembolization

  Response mRECIST
Responder Non responder
Count Percentage Count Percentage
Response vRECIST Responder 13 92.9% 25 69.4%
Nonresponder 1 7.1% 11 30.6%
Measure of agreement Kappa P value
.154 .140